Literature DB >> 16148551

Should patients with coeliac disease have their bone mineral density measured?

Nina R Lewis1, Brian B Scott.   

Abstract

BACKGROUND: In 1998 we published guidelines for managing osteoporosis in coeliac disease. These guidelines recommended bone mineral density (BMD) measurement at diagnosis. We analyse the results of following these guidelines in a district general hospital with a view to rationalizing screening. PATIENTS AND METHODS: Forty-three consecutive patients with newly diagnosed coeliac disease had dual-energy X-ray absorptiometry scans of the hip and lumbar spine. Results were correlated with factors that were suspected to influence BMD and were compared with comparable published studies.
RESULTS: Osteoporosis at the hip and spine was found in only 7% and 14% of patients, respectively. Mean z scores were not significantly reduced. BMD did not correlate with the duration of gluten exposure, symptoms, degree of villous atrophy, or smoking. At the hip, but not at the spine, there was a significant correlation between BMD and the body mass index.
CONCLUSIONS: The surprisingly low yield of reduced BMD, together with doubt about increased fracture rates in coeliac patients, does not support the current recommendations for screening BMD at diagnosis, and the guidelines should be changed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148551     DOI: 10.1097/00042737-200510000-00009

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  14 in total

1.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

Review 2.  Age-related differences in celiac disease: Specific characteristics of adult presentation.

Authors:  Santiago Vivas; Luis Vaquero; Laura Rodríguez-Martín; Alberto Caminero
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

Review 3.  Evaluation and management of skeletal health in celiac disease: position statement.

Authors:  Mona A Fouda; Aliya A Khan; Muhammad Saad Sultan; Lorena P Rios; Karen McAssey; David Armstrong
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

4.  The clinical significance of 25OH-Vitamin D status in celiac disease.

Authors:  Aaron Lerner; Yinon Shapira; Nancy Agmon-Levin; Avi Pacht; Dana Ben-Ami Shor; Hoyos Marcus López; Maria Sanchez-Castanon; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

5.  Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.

Authors:  Tamara Matysiak-Budnik; Georgia Malamut; Natacha Patey-Mariaud de Serre; Etienne Grosdidier; Sylvie Seguier; Nicole Brousse; Sophie Caillat-Zucman; Nadine Cerf-Bensussan; Jacques Schmitz; Christophe Cellier
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

Review 6.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

Review 7.  Long-term follow-up of individuals with celiac disease: an evaluation of current practice guidelines.

Authors:  Jocelyn A Silvester; Mohsin Rashid
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

Review 8.  Bone in celiac disease.

Authors:  M-L Bianchi; M T Bardella
Journal:  Osteoporos Int       Date:  2008-04-17       Impact factor: 4.507

9.  Bone mineralization in celiac disease.

Authors:  Tiziana Larussa; Evelina Suraci; Immacolata Nazionale; Ludovico Abenavoli; Maria Imeneo; Francesco Luzza
Journal:  Gastroenterol Res Pract       Date:  2012-04-18       Impact factor: 2.260

10.  Risk factors associated with osteoporosis in a cohort of prospectively diagnosed adult coeliac patients.

Authors:  Gloria Galli; Edith Lahner; Laura Conti; Gianluca Esposito; Maria Carlotta Sacchi; Bruno Annibale
Journal:  United European Gastroenterol J       Date:  2018-06-12       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.